The Decrease of Mineralcorticoid Receptor Drives Angiogenic Pathways in Colorectal Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Tiberio, Laura ^a   Nascimbeni, Riccardo ^a,b   Villanacci, Vincenzo ^b   Casella, Claudio ^a,b   Fra, Anna ^a   Vezzoli, Valeria ^c   Furlan, Lucia ^d   Meyer, Giuliano ^c   Parrinello, Giovanni ^a   Baroni, Maurizio D ^d   Salerni, Bruno ^a,b   Schiaffonati, Luisa ^d  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Brescia General Hospital   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE DERIVATIVE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL STRAIN HCT116; CLINICAL ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ALDOSTERONE; CELL HYPOXIA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84875526247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059410     Document Type: Article

References (40)

1. Horisberger JD, Rossier BC, (1992) Aldosterone regulation of gene transcription leading to control of ion transport. Hypertension 19: 221-7.
2. Bonvalet JP (1998) Regulation of sodium transport by steroid hormones. Kidney Int Suppl 65: S49-56.
3. Meijer OC, (2002) Coregulator proteins and corticosteroid action in the brain. J Neuroendocrinol 14: 499-505.
4. Lombes M, Farman N, Bonvalet JP, Zennaro MC, (2000) Identification and role of aldosterone receptors in the cardiovascular system. Ann Endocrinol (Paris) 61: 41-6.
5. Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, et al. (2007) The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal 5: e012.
6. Dooley R, Harvey BJ, Thomas W, (2012) Non-genomic actions of aldosterone: From receptors and signals to membrane targets. Mol Cell Endocrinol 350: 223-34.
7. Yang J, Young MJ, (2009) The mineralocorticoid receptor and its coregulators. J Mol Endocrinol 43: 53-64.
8. Pascual-Le Tallec L, Lombes M, (2005) The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol Endocrinol 19: 2211-21.
9. Oyamada N, Sone M, Miyashita K, Park K, Taura D, et al. (2008) The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia. Endocrinology 149: 3764-77.
10. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, et al. (2002) Aldosterone-Induced Inflammation in the Rat Heart: Role of Oxidative Stress. The American Journal of Pathology 161: 1773-81.
11. Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, et al. (2006) Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 47: 671-9.
12. Kobayashi N, Fukushima H, Takeshima H, Koguchi W, Mamada Y, et al. (2010) Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb. Am J Hypertens 23: 1007-13.
13. Thum T, Schmitter K, Fleissner F, Wiebking V, Dietrich B, et al. (2011) Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans. Eur Heart J 32: 1275-86.
14. Hirota K, Semenza GL, (2006) Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59: 15-26.
15. Brahimi-Horn MC, Chiche J, Pouyssegur J, (2007) Hypoxia and cancer. J Mol Med (Berl) 85: 1301-7.
16. Ferrara N, Gerber HP, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-76.
17. Duff SE, Jeziorska M, Rosa DD, Kumar S, Haboubi N, et al. (2006) Vascular endothelial growth factors and receptors in colorectal cancer: implications for anti-angiogenic therapy. Eur J Cancer 42: 112-7.
18. Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, et al. (2003) The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 200: 183-94.
19. Tugues Sn, Koch S, Gualandi L, Li X, Claesson-Welsh L, (2011) Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer. Molecular Aspects of Medicine 32: 88-111.
20. Giatromanolaki A, Koukourakis MI, Sivridis E, Chlouverakis G, Vourvouhaki E, et al. (2007) Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer. Eur J Clin Invest 37: 878-86.
21. Calvani M, Trisciuoglio D, Bergamaschi C, Shoemaker RH, Melillo G, (2008) Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells. Cancer Res 68: 285-91.
22. Di Fabio F, Alvarado C, Majdan A, Gologan A, Voda L, et al. (2007) Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression. J Gastrointest Surg 11: 1521-8.
23. Jeong Y, Xie Y, Xiao G, Behrens C, Girard L, et al. (2010) Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med 7: e1000378.
24. Vieira SC, Silva BB, Pinto GA, Vassallo J, Moraes NG, et al. (2005) CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathol Res Pract 201: 313-8.
25. Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D, et al. (1998) Antagonism in the human mineralocorticoid receptor. Embo J 17: 3317-25.
26. Gouilleux F, Sola B, Couette B, Richard-Foy H, (1991) Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucleic Acids Res 19: 1563-9.
27. Keira SM, Ferreira LM, Gragnani A, Duarte I, Campaner AB, et al. (2004) Experimental model for establishment of hypoxia in 75 cm2 culture flasks. Acta Cir Bras (serial online) 19: 23-7.
28. Tiberio L, Tiberio GA, Bardella L, Cervi E, Cerea K, et al. (2006) Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver. Cytokine 34: 131-42.
29. Muller PY, Janovjak H, Miserez AR, Dobbie Z (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-4, 6, 8-9.
30. Gomez-Sanchez CE, Warden M, Gomez-Sanchez MT, Hou X, Gomez-Sanchez EP, (2011) Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies. Steroids 76: 1541-5.
31. Bergann T, Ploger S, Fromm A, Zeissig S, Borden SA, et al. (2009) A colonic mineralocorticoid receptor cell model expressing epithelial Na+ channels. Biochem Biophys Res Commun 382: 280-5.
32. Krug AW, Grossmann C, Schuster C, Freudinger R, Mildenberger S, et al. (2003) Aldosterone stimulates epidermal growth factor receptor expression. J Biol Chem 278: 43060-6.
33. Latouche C, Sainte-Marie Y, Steenman M, Castro Chaves P, Naray-Fejes-Toth A, et al. (2010) Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart. Endocrinology 151: 4467-76.
34. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5.
35. Bertrand C, Kowalski-Chauvel A, Do C, Resa C, Najib S, et al. (2010) A gastrin precursor, gastrin-gly, upregulates VEGF expression in colonic epithelial cells through an HIF-1-independent mechanism. Int J Cancer 126: 2847-57.
36. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, et al. (2003) The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4: 133-46.
37. Tang N, Wang L, Esko J, Giordano FJ, Huang Y, et al. (2004) Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6: 485-95.
38. Fujii M, Inoki I, Saga M, Morikawa N, Arakawa KI, et al. (2012) Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma. J Steroid Biochem Mol Biol 129: 145-52.
39. Grossmann C, Gekle M, (2009) New aspects of rapid aldosterone signaling. Mol Cell Endocrinol 308: 53-62.
40. Mihailidou AS, Funder JW, (2005) Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system. Steroids 70: 347-51.